Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
7.66M
-
Shares change
-
+475K
-
Total reported value, excl. options
-
$18.5M
-
Value change
-
+$1.15M
-
Put/Call ratio
-
1.12
-
Number of buys
-
17
-
Number of sells
-
-24
-
Price
-
$2.42
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q4 2024
67 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q4 2024.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.66M shares
of 41M outstanding shares and own 18.69% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (2.64M shares), Murchinson Ltd. (1.75M shares), BOOTHBAY FUND MANAGEMENT, LLC (845K shares), Rathbones Group PLC (290K shares), TWO SIGMA ADVISERS, LP (241K shares), Peapod Lane Capital LLC (227K shares), BANK OF AMERICA CORP /DE/ (168K shares), RENAISSANCE TECHNOLOGIES LLC (152K shares), DIMENSIONAL FUND ADVISORS LP (119K shares), and UBS Group AG (113K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.